Testing effectiveness (Phase 2)Looking for participantsNCT07025889What this trial is testingIBI343 Combined With Sintilimab Plus Chemotherapy in Gastric CancerWho this might be right forGastric Cancer Ruijin Hospital 55
Testing effectiveness (Phase 2)Study completedNCT02730546What this trial is testingPembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by SurgeryWho this might be right forGastric Cardia AdenocarcinomaGastroesophageal Junction AdenocarcinomaStage IB Gastric Cancer AJCC v7+5 more Mayo Clinic 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT06944496What this trial is testingDisitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric Carcinoma RemeGen Co., Ltd. 616
Early research (Phase 1)Active Not RecruitingNCT05156866What this trial is testingFirst in Human Study of TORL-2-307-ADC in Participants With Advanced CancerWho this might be right forAdvanced Solid TumorGastric CancerPancreas Cancer+1 more TORL Biotherapeutics, LLC 163
Testing effectiveness (Phase 2)WithdrawnNCT05678205What this trial is testingA Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid TumorsWho this might be right forBreast CancerGastric CancerGastroesophageal Junction Adenocarcinoma Artiva Biotherapeutics, Inc.
Early research (Phase 1)Enrolling By InvitationNCT07218003What this trial is testingA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Who this might be right forNon Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more Rondo Therapeutics 149
Testing effectiveness (Phase 2)Study completedNCT01472029What this trial is testingExplorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or StomachWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach AIO-Studien-gGmbH 53
Testing effectiveness (Phase 2)Study completedNCT01630083What this trial is testingEfficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric CancerWho this might be right forCLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of EsophagusCLDN18.2-positive Gastric Adenocarcinoma Astellas Pharma Global Development, Inc. 252
Testing effectiveness (Phase 2)UnknownNCT04792515What this trial is testingCamrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric CancerWho this might be right forLocally Advanced Gastric Cancer First Affiliated Hospital Xi'an Jiaotong University 67
Testing effectiveness (Phase 2)Looking for participantsNCT06766578What this trial is testingClinical Study of Low-dose Interval Radiotherapy Combined With Tirelizumab and SOX Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaWho this might be right forLocally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma Shandong Provincial Hospital 32
Testing effectiveness (Phase 2)UnknownNCT02525237What this trial is testingApatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric CancerWho this might be right forGastric Cancer Qingdao Municipal Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00006081What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer M.D. Anderson Cancer Center 37
Large-scale testing (Phase 3)UnknownNCT04385550What this trial is testingAnlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction AdenocarcinomaWho this might be right forAdvanced Gastric and Gastro-oesophageal Junction Adenocarcinoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 528
Large-scale testing (Phase 3)Study completedNCT02625623What this trial is testingAvelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)Who this might be right forUnresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaGastric Cancer Third Line EMD Serono Research & Development Institute, Inc. 371
Post-approval studies (Phase 4)Not Yet RecruitingNCT07829757What this trial is testingZolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric CancerWho this might be right forLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07692334What this trial is testingBecotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ AdenocarcinomaWho this might be right forGastric CancerGastroesophageal Junction (GEJ) AdenocarcinomaBecotatug Vedotin+1 more West China Second University Hospital 28
Early research (Phase 1)Study completedNCT01561014What this trial is testingOxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach+5 more Wake Forest University Health Sciences 9
Large-scale testing (Phase 3)Looking for participantsNCT07284134What this trial is testingJS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.Who this might be right forAdvanced Gastric or Gastroesophageal Junction Adenocarcinoma Shanghai Junshi Bioscience Co., Ltd. 560
Testing effectiveness (Phase 2)UnknownNCT03139487What this trial is testingPhase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismWho this might be right forCancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more Asan Medical Center 176
Early research (Phase 1)WithdrawnNCT06341647What this trial is testingPhase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201Who this might be right forBreast CancerGastric CancerGastroesophageal Junction Adenocarcinoma GC Cell Corporation